Category: Health Canada News
-
Health Canada And FDA Issue Adverse Reaction Updates In Second Half Of 2010 Which Involve Popular Drug Zocor (Simvastatin)
Cases Of Interstitial Lung Disease (ILD) And Rhabdomyolysis / Myopathy Associated With Cholesterol Drugs Known As Statins, Including Zocor (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: FDA Drug Safety Communication: New restrictions, contraindications,…
-
Osteoporosis Medication Aclasta Associated With Renal Impairment And Kidney Failure
Novartis Sends "Dear Doctor" Letter To Canadian Physicians With Health Canada Endorsed Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In 2007 Aclasta (zoledronic acid 5mg) was approved by the FDA under the brand name Aclasta®…
-
Antibiotic Avelox Linked To Severe Liver Injury Side Effects, Again
Will The FDA Be The Last To Insist On Increased Warning; In Fall 2007 Bayer Updated Its Avalox Label In Europe (Posted by Tom Lamb at DrugInjuryWatch.com) On March 22, 2010 Health Canada issued a press…
-
FDA And Novartis Announce A Label Change For Iron Chelating Drug Exjade In Mid-February 2010
Includes A New "Black Box" Warning About Renal Impairment, Liver Failure, And Gastrointestinal Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 the FDA and Novartis announced a change to the Prescribing Information…
-
Levaquin Has Been Associated With Dysglycemia Events Such As Hyperglycemia And Hypoglycemia
North Carolina Case Report: Man With Diabetes Develops Low Blood Sugar After Using Levaquin Together With Glucotrol (Posted by Tom Lamb at DrugInjuryWatch.com) Three years ago to the day we posted an article, back in…
-
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems
Serious Side Effects Include Heart Attacks, Abnormal Heart Rhythms, Heart Failure, And Various Conditions Caused By Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Xolair Is Associated With Higher Than Expected Reporting…
-
History Of Singulair And Psychiatric Adverse Reactions In Canada: 1997 – January 2009
July 2009 Canadian Adverse Reaction Newsletter Provides Summary Of Reports Made To Health Canada (Posted by Tom Lamb at DrugInjuryWatch.com) Singulair (montelukast) has been marketed in Canada since 1997. In Canada Singulair is indicated…
-
Serious Problems With Generic Drug Makers In U.S. Continue To Be Discovered
The Safety Spotlight Has Been On Big Pharma In Recent Years; What Have These Lesser Known Manufacturers Been Getting Away With? (Posted by Tom Lamb at DrugInjuryWatch.com) A little more than two weeks ago…
-
Tequin Revisited: Health Canada And The FDA Failed To Take Action, At Our Expense
Bristol-Myers Squibb Was Allowed To Withdraw Their Unsafe Drug For "Economic Reasons", And Only After Selling Off Its Inventory (Posted by Tom Lamb at DrugInjuryWatch.com) An article by Joel Lexchin, MSc MD, "Information about…
-
More Reports Of Serious Blood Clots In Women Using Birth Control Patch Or Vaginal Ring
January 2008 Health Canada Newsletter Presents These Adverse Reaction Cases, And Announces "Canada Vigilance" (Posted by Tom Lamb at DrugInjuryWatch.com) The Canadian Adverse Reaction Newsletter (CARN), in its January 2008 edition (Volume 18, Issue…